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Abstract
Background: Salvia leriifolia have been shown to decrease ischemia-reperfusion (I/R) injury in brain
tissues. In this study, the effects of S. leriifolia aqueous and ethanolic extracts were evaluated on an
animal model of I/R injury in the rat hind limb.
Methods: Ischemia was induced using free-flap surgery in skeletal muscle. The aqueous and
ethanolic extracts of S. leriifolia (100, 200 and 400 mg/kg) root and normal saline (10 ml/kg) were
administered intraperitoneally 1 h prior reperfusion. During preischemia, ischemia and reperfusion
conditions the electromyographic (EMG) potentials in the muscles were recorded. The markers of
oxidative stress including thiobarbituric acid reactive substances (TBARS), total sulfhydryl (SH)
groups and antioxidant capacity of muscle (using FRAP assay) were measured.
Results: In peripheral ischemia, the average peak-to-peak amplitude during ischemic-reperfusion
was found to be significantly larger in extracts groups in comparison with control group. Following
extracts administration, the total SH contents and antioxidant capacity were elevated in muscle
flap. The MDA level was also declined significantly in test groups.
Conclusion: It is concluded that S. leriifolia root extracts have some protective effects on different
markers of oxidative damage in muscle tissue injury caused by lower limb ischemia-reperfusion.
Background
A vast amount of circumstantial evidence implicates oxy-
gen-derived free radicals (especially superoxide and
hydroxyl radical) and high-energy oxidants (such as per-
oxynitrite) are as mediators of inflammation, shock, and
ischemia/reperfusion injury [1]. The oxidant injury can
potentially occur during ischemia and reperfusion due to
an excess production of oxygen free radicals, a decrease in
antioxidant defenses, or both. Because antioxidants func-
tion by removing the toxic oxygen metabolites, they are
generally highly effective in reducing ischemia-reper-
fusion injury [2]. Skeletal muscle ischemia and reper-
fusion injury remains an issue of concern because of the
morbidity and mortality that follows revascularization of
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an acutely ischemic limb [3]. Many studies have suggested
the beneficial antioxidant effects of antioxidant nutrients
such as vitamin E, green tea extract, ginkgo biloba extract,
resveratrol and niacin in cerebral ischemia and recircula-
tion brain injury [4].
The plants of the genus Salvia, which consist about 900
species [5] are generally known for their multiple pharma-
cological effects such as analgesic and anti-inflammatory
[6], antioxidant [7], hepatoprotective [8] and hypoglyc-
emic activities [9]. Salvia leriifolia that was introduced in
flora Iranica in 1982 [10] geographically grows in the
south and tropical regions of Khorassan and Semnan
provinces, I.R. Iran. In recent years, the different pharma-
cological activities of this plant such as the attenuation of
morphine dependence [11], hypoglycemic [12], analgesic
and anti-inflammatory [13,14], anticonvulsant [15], anti-
ulcer effects [16] and antibacterial activities [17] were
evaluated in our laboratory.
The anti-ischemia effects of some species of Salvia such as
S. hematodes and  S. miltiorrhiza [18,19] have been
reported. Our studies also showed the anti-ischemia
effects of S. leriifolia extracts in hippocampus of rats [20].
Thus, in this study the effect of S. leriifolia extract was eval-
uated during ischemia-reperfusion on an animal model of
I/R injury in the rat hind limb.
Methods
Animals
Wistar male rats, 200–230 g were housed in colony rooms
with 12/12 h light/dark cycle at 21 ± 2°C and had free
access to food and water. All animal experiments were car-
ried out in accordance with Mashhad University of Medi-
cal Sciences, Ethical Committee Acts.
Chemicals
TBA, n- butanol, phosphoric acid, potassium chloride and
thiobarbituric acid were purchased from Merck. Xylazine
and ketamine were obtained from Loughrea, Co. (Galway,
Ireland) and Rotexmedica (GmbH, Germany), respec-
tively. All chemical were dissolved in distilled water.
Induction of ischemia
The rats were anesthetized with intraperitoneal injection
of ketamine/xylazine (60 mg/kg and 6 mg/kg, respec-
tively). Additional doses of these agents were used if
anesthesia lightened during experiment.
An incision in the inner side of the hind leg from the
inguinal ligament to the tendon calcaneus insertion was
made. Then it was divided up and the triceps surae was
dissected as a muscle flap, after that insertions to femur
was cut. Previously dissected femoral vessels, the artery
and vein were clamped with a single clamp of microsur-
gery. The absence of bleeding was verified in the muscle
flap. Then the incision was closed to prevent desiccation.
For reperfusion periods, the clamp of the femoral vessels
of animals was taken off and then the bleeding of the
muscle flap was verified. The muscle tissues was homoge-
nized in cold KCl solution (1.5%) to give a 10% homog-
eny suspension and used for biochemical assays. The
results were expressed by n or μM/g tissue (1 ml of
homogenate = 0.1 g of tissue) [49].
Eight groups of animals were used, each of which con-
tained 8 rats: Group 1 including sham operated animals,
Group 2 served as ischemic control to which saline (10
ml/kg) was injected intraperitoneally (i.p.). Group 3–8
was received the aqueous and ethanolic extract (100, 200
and 400 mg/kg). Except group 1, other groups underwent
2 h ischemia and 1 h reperfusion. All drugs were adminis-
trated 1 h before reperfusion.
Electromyography data collection
To determine the muscles activities during ischemia-
reperfusion, intramuscular electromyograph (EMG) sig-
nals were recorded with PowerLab data acquisition sys-
tems. Two pairs of pin electrodes in terminating alligator
clips were inserted into the triceps surae (muscle flap) in
hind leg, and adductor muscles. The distance between the
two electrodes of a pair in each muscle was 5 mm. A
grounding electrode was gently attached to the rat tail
[50]. The EMG signals were collected with sampling fre-
quency of 12 PPM (MacLab/4SP). Duration for each stim-
ulation was 20 ms. The raw EMG signals were low-pass
filtered at 50 Hz and EMG signal is expressed as average
peak-to-peak amplitude for a 10 min recording periods.
The electromyography (EMG) signals were recorded 10
min before ischemia, 10 min before reperfusion and 10
min at end of reperfusion phase.
Preparation of Salvia leriifolia extracts
S. leriifolia was collected from Bajestan (Razavi Khorasan
province, Northeast of Iran) and authenticated by Phar-
macognosy Department, School of Pharmacy, MUMS,
Iran (Voucher No:153-1912-05). For preparation of aque-
ous extract, the powdered root (100 g) was boiled in 1000
ml boiling water for 15 min. Subsequently, the mixture
was filtered and concentrated under reduced pressure at
35°C (yield: 5.5% w/w). As some constituents are sensi-
tive to boiling water we also prepared a macerated extract.
For preparation of the ethanolic extract, the powdered
root (100 g) was macerated in 1000 ml ethanol (96% v/v)
for 72 h and subsequently the mixture was filtered and
concentrated under reduced pressure at 35°C (yield: 6%
w/w).BMC Complementary and Alternative Medicine 2007, 7:23 http://www.biomedcentral.com/1472-6882/7/23
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Preliminary chemical tests
Phytochemical screening of the extract was performed
using the following reagents and chemicals (Trease and
Evans, 1983): alkaloids with Dragendorff's reagent, flavo-
noids with the use of Mg and HC1.; tannins with 1 % gel-
atin and 10% NaCl solutions and saponins with ability to
produce suds and hemolysis reaction [51].
Characterization of aqueous and ethanolic extracts by HPLC
The quality of extracts of S. leriifolia radix was character-
ized by HPLC finger print. The aqueous and ethanolic
extracts were dissolved in distilled water and acetonitrile
respectively and then filtered through 0.22 μm membrane
filter. Twenty μl of sample (10 g/l) was injected to the
reverse phase column (C18). The mobile phase was con-
sisted water: phosphoric acid 1N, 99:1 (as solvent A) and
acetonitrile: phosphoric acid 1N, 99:1 (as solvent B) with
a gradient elution (0, 95:5; 5, 92.5:7.5; 10, 90:10; 15,
87.5:12.5; 20, 85:15; 25, 82.5:17.5; 30, 80:20; 35,
78.5:22.5, 40, 75:25) at the flow rate of 1 ml/minute. The
peaks were monitored at 236 nm.
Thiobarbituric acid reactive substances (TBARS) 
measurement
Malondialdehyde (MDA) levels, as an index of lipid per-
oxidation, were measured. MDA reacts with thiobarbituric
acid (TBA) as a thiobarbituric acid reactive substance
(TBARS) to produce a red colored complex which has
peak absorbance at 532 nm [52].
3 ml phosphoric acid (1%) and 1 ml TBA (0.6%) was
added to 0.5 ml of homogenate in a centrifuge tube and
the mixture was heated for 45 min in a boiling water bath.
After cooling, 4 ml of n-butanol was added the mixture
and vortex-mixed for 1 min followed by centrifugation at
20000 rpm for 20 min. The organic layer was transferred
to a fresh tube and its absorbance was measured at 532
nm. The standard curve of MDA was constructed over the
concentration range of 0–40 μM [53].
Ferric Reducing/Antioxidant Power (FRAP) assay
The FRAP assay measures the change in absorbance at 593
nm owing to the formation of a blue colored Fe2+-tripyri-
dyltriazine compound from the colorless oxidized Fe3+
form by the action of electron donating antioxidants [54].
The FRAP reagent consist of 300 mM acetate buffer (3.1 g
sodium acetate + 16 ml glacial acetic acid, made up to 1
liter with distilled water; pH = 3.6), 10 mM TPTZ in 40
mM HCl and 20 mM FeCl3.6H2O in the ratio of 10:1:1.
Briefly, 50 μl of muscle homogenate was added to 1.5 ml
freshly prepared and prewarmed (37°C) FRAP reagent in
a test tube and incubated at 37°C for 10 min. The absorb-
ance of the blue colored complex was read against reagent
blank (1.5 ml FRAP reagent + 50 μl distilled water) at 593
nm. Standard solutions of Fe2+ in the range of 100 to 1000
mM were prepared from ferrous sulphate (FeSO4.7H2O)
in distilled water. The data was expressed as mM ferric
ions reduced to ferrous form per liter (FRAP value) [55].
Total sulfhydryl (SH) groups assay
Total SH groups were measured using DTNB (2, 2'-dini-
tro-5, 5'-dithiodibenzoic acid) as the reagent. This reagent
reacts with the SH groups to produce a yellow colored
complex which has a peak absorbance at 412 nm [56].
Briefly, 1 ml Tris-EDTA buffer (pH = 8.6) was added to 50
μl muscle homogenate in 2 ml cuvettes and sample
absorbance was read at 412 nm against Tris-EDTA buffer
alone (A1). Then 20 μl DTNB reagent (10 mM in metha-
nol) was added to the mixture and after 15 min (stored in
laboratory temperature) the sample absorbance was read
again (A2). The absorbance of DTNB reagent was also read
HPLC fingerprint of the ethanolic (A) and aqueous (B)  extracts of Salvia leriifolia root Figure 1
HPLC fingerprint of the ethanolic (A) and aqueous (B) 
extracts of Salvia leriifolia root.
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as a blank (B). Total thiol concentration (mM) was calcu-
lated from the following equation:
Total thiol concentration (mM) = (A2-A1-B) × 1.07/0.05 ×
13.6
Statistical analysis
Data are expressed as mean ± SEM. Statistical analysis was
performed using one-way ANOVA followed by Tukey-
Kramer post-hoc test for multiple comparisons. The p-val-
ues less than 0.05 were considered to be statistically signif-
icant.
Results
Chemical analysis
Preliminary phytochemical tests indicated that the aque-
ous and ethanolic extracts of S. leriifolia radix contain tan-
nins and saponins. Alkaloids were found in low amount
Effect of Salvia leriifolia root ethanolic extract on lipid peroxi- dation following muscle ischemia reperfusion injury Figure 3
Effect of Salvia leriifolia root ethanolic extract on lipid peroxi-
dation following muscle ischemia reperfusion injury. MDA 
levels were measured in 10% homogenates of muscle sam-
ples from rats subjected to 120 min of ischemia and 60 min 
of reperfusion. All drugs were administrated intraperitoneally 
60 min prior to reperfusion. Values are mean ± SEM (n = 8). 
**p < 0.01, ***p < 0.001 as compared with vehicle (normal 
saline) treated animals (One-way ANOVA followed by 
Tukey-Kramer test)
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Table 1: Effects of Salvia leriifolia root aqueous and ethanolic extracts on average peak-to-peak amplitudes of EMG signals, prior, 
during and after ischemia-reperfusion in rat skeletal muscle.
Group (n = 8) Preischemia (v) Ischemia (v) Reperfusion (v)
Sham 2.590 ± 0.015 2.671 ± 0.018*** 2.588 ± 0.033***
Control group (10 ml/kg) 2.800 ± 0.044 1.314 ± 0.027 1.495 ± 0.025
Aqueous extract 100 mg/kg 2.038 ± 0.023 2.110 ± 0.030*** 1.867 ± 0.067**
Aqueous extract 200 mg/kg 2.214 ± 0.036 2.296 ± 0.016*** 2.303 ± 0.034***
Aqueous extract 400 mg/kg 2.440 ± 0.030 2.425 ± 0.013*** 2.112 ± 0.025***
Ethanolic extract 100 mg/kg 2.040 ± 0.027 2.098 ± 0.033*** 1.846 ± 0.075**
Ethanolic extract 200 mg/kg 2.190 ± 0.039 2.291 ± 0.019*** 2.308 ± 0.041***
Ethanolic extract 400 mg/kg 2.430 ± 0.035 2.422 ± 0.014*** 2.098 ± 0.024***
Values are mean ± S.E.M. ** P < 0.01 and ***P < 0.001 when compared with control group with Tukey-Kramer test.
Effect of Salvia leriifolia root aqueous extract on lipid peroxi- dation following muscle ischemia reperfusion injury Figure 2
Effect of Salvia leriifolia root aqueous extract on lipid peroxi-
dation following muscle ischemia reperfusion injury.MDA lev-
els were measured in 10% homogenates of muscle samples 
from rats subjected to 120 min of ischemia and 60 min of 
reperfusion. All drugs were administrated intraperitoneally 
60 min prior to reperfusion. Values are mean ± SEM (n = 8). 
**p < 0.01, ***p < 0.001 as compared with vehicle (normal 
saline) treated animals (One-way ANOVA followed by 
Tukey-Kramer test)
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in the ethanolic extract. HPLC fingerprints of aqueous and
ethanolic extracts indicated a relatively different pattern.
(Fig. 1A and 1B).
Electromyography data
The average peak-to-peak amplitudes in the control-
ischemic group and sham were 1.314 ± 0.027, 1.495 ±
0.025 V and 2.671 ± 0.018, 2.588 ± 0.033 V, p < 0.001)
respectively during ischemia and reperfusion. The aque-
ous and ethanolic extracts increased the amplitude com-
pare with ischemia and reperfusion groups (Table 1).
Thiobarbituric acid reactive species (TBARS) measurement
There was an increase in the MDA levels following
ischemia reperfusion as compared with sham-operated
animals (20.18 ± 3.65 vs 88.53 ± 3.65 nM/g tissue, p <
0.01) (Figure 2 and 3). The extracts pretreatment resulted
in a significant reduction in the free radical-mediated lipid
peroxidation as indicated by a decrease in the MDA levels,
at various dose levels (Figures 2 and 3). A reduction in
TBARS levels was very prominent in the higher doses.
Modulation of FRAP value
Ischemia reperfusion caused a significant reduction in
FRAP value of muscle homogenate samples as compared
with sham-operated animals (2.620 ± 0.148 vs. 1.076 ±
0.119  μM/g tissue, p < 0.001) (Figure 4 and 5). The
extracts pretreatment increased antioxidant power (FRAP
value) of muscle homogenate samples (Figures 4 and 5).
Total thiol concentration
Following ischemia-reperfusion injury, a significant
reduction in total SH groups (0.728 ± 0.027 vs. 0.215 ±
0.010 mM, p < 0.001) in muscle homogenate samples was
observed (Figure 7). The extracts pretreatment caused a
significant elevation in total thiol concentration, as com-
pared with control-ischemic group (Figures 6 and 7).
Discussion
The results obtained in the present investigation suggest
that the S. leriifolia extracts have an overall protective
effect against muscle I/R injury in a rat model.
A number of processes have been implicated in the patho-
genesis of oxygen deprivation-induced cell injury. These
Effect of Salvia leriifolia root ethanolic extract on antioxidant  power of muscle homogenate samples following muscle  ischemia reperfusion injury Figure 5
Effect of Salvia leriifolia root ethanolic extract on antioxidant 
power of muscle homogenate samples following muscle 
ischemia reperfusion injury. FRAP values were measured in 
10% homogenate samples from rats subjected to 120 min of 
ischemia and 60 min of reperfusion. All drugs were adminis-
trated intraperitoneally 60 min prior to reperfusion. Values 
are mean ± SEM (n = 8). **p < 0.01, ***p < 0.001 as com-
pared with vehicle (normal saline) treated animals (One-way 
ANOVA followed by Tukey-Kramer test)
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Effect of Salvia leriifolia root aqueous extract on antioxidant  power of muscle homogenate samples following muscle  ischemia reperfusion injury Figure 4
Effect of Salvia leriifolia root aqueous extract on antioxidant 
power of muscle homogenate samples following muscle 
ischemia reperfusion injury. FRAP values were measured in 
10% homogenate samples from rats subjected to 120 min of 
ischemia and 60 min of reperfusion. All drugs were adminis-
trated intraperitoneally 60 min prior to reperfusion. Values 
are mean ± SEM (n = 8). ***p < 0.001 as compared with vehi-
cle (normal saline) treated animals (One-way ANOVA fol-
lowed by Tukey-Kramer test)
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include the disturbances of cell calcium homeostasis,
depletion of adenine nucleotides, activation of enzymes
like phospholipases with production of toxic lipid metab-
olites, proteases and endonucleases and generation of free
radicals (ROS) that can cause oxidative damage to cellular
macromolecules [21,22]. Antioxidant therapy has been
well documented to help in the improvement of organ
functions [23].
We assessed the effect of the S. leriifolia extracts studying
their effects on lipid peroxidation, which was measured in
terms of MDA, a stable metabolite of the free radical-
mediated lipid peroxidation cascade. MDA levels
increased significantly following muscle ischemia reper-
fusion. The S. leriifolia extracts reversed the increase of
MDA levels to a considerable extent, thereby confirming
its antioxidant role in I/R.
Sulfhydryl (SH) groups are highly-reactive constituents of
protein molecules, and they participate in important bio-
chemical and metabolic process such as cell division,
blood coagulation, maintenance of protein systems and
enzymatic activation including antioxidant enzymes (cat-
alase, superoxide dismutase, etc.) [24]. There are also
important scavengers of oxygen-derived free radicals [25].
SH groups known to be sensitive to oxidative damage and
depleted following ischemic insult [26], therefore we
studied the effect of the aqueous and ethanolic extracts of
S. leriifolia on total thiol concentration during muscle
ischemia reperfusion. Similarly, in our studies, total sulf-
hydryl groups were decreased following I/R injury. These
agents exhibited higher SH contents than their respective
controls, indicating that helped in replenishing the total
thiol pool.
Under acute and chronic pathologic conditions such as
ischemia, the balance between oxidant and antioxidant
systems has been interrupted [27,28]. Therefore we evalu-
ate the antioxidant or reducing potential of muscle
homogenate samples following muscle ischemia reper-
fusion, using FRAP assay. As expected following this, a sig-
nificant reduction in antioxidant power, as indicated by
FRAP value, was observed. The aqueous and ethanolic
extracts increased the antioxidant power of muscle
homogenate samples.
Effect of Salvia leriifolia root ethanolic extract on total thiol  concentrations following muscle ischemia reperfusion injury Figure 7
Effect of Salvia leriifolia root ethanolic extract on total thiol 
concentrations following muscle ischemia reperfusion injury. 
Total sulfhydryl (SH) groups were measured in 10% muscle 
homogenate samples from rats subjected to 120 min of 
ischemia and 60 min of reperfusion. All drugs were adminis-
trated intraperitoneally 60 min prior to reperfusion. Values 
are mean ± SEM (n = 8). *p < 0.05, ***p < 0.01 as compared 
with vehicle (normal saline) treated animals (One-way 
ANOVA followed by Tukey-Kramer test).
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Effect of Salvia leriifolia root aqueous extract on total thiol  concentrations following following muscle ischemia reper- fusion injury Figure 6
Effect of Salvia leriifolia root aqueous extract on total thiol 
concentrations following following muscle ischemia reper-
fusion injury. Total sulfhydryl (SH) groups were measured in 
10% muscle homogenate samples from rats subjected to 120 
min of ischemia and 60 min of reperfusion. All drugs were 
administrated intraperitoneally 60 min prior to reperfusion. 
Values are mean ± SEM (n = 8). ***p < 0.01 as compared 
with vehicle (normal saline) treated animals (One-way 
ANOVA followed by Tukey-Kramer test).
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The S. leriifolia extracts showed anti-ischemia activity in
this study. Phytochemical test showed that the extracts
comprised saponins and tannins. Antihypoxic and anti-
ischemic activities of some of these components such as
protopanaxatriol and ginsenosides have been reported
[29-31]. Monoterpenes as the one of the constituents of
the essential oil of S. leriifolia showed good antioxidant
activity [32]. There are several reports about the antioxi-
dant activity and anti-inflammatory effects of some
monoterpenoids such as α-pinene. Moreover, there have
been shown monoterpenoids such as terpineol and lina-
lool have depressant effects on central nervous system, in
vivo [32] and linalool competitively inhibits glutamate
receptors [33]. However, the chemical constituents
responsible for the pharmacological activities of the
extracts remain to be investigated. Phytochemical assays
and HPLC finger prints showed a little difference between
these two extracts but it seems this variation does not
affect on anti-ischemia effects. The maximum effect was
shown with higher doses of both extracts
It seems that ischemia reperfusion injury reduced the con-
ductivity and viability of muscles and nerves. In this study,
the S. leriifolia extracts maintained the nerve conductivity.
Nerve conduction is decreased during ischemia-reper-
fusion [34,35]. Mild muscle necrotic changes occur after
2–3 h ischemia [36,37]. Oxidative stress and the produc-
tion of oxygen free radicals during ischemia-reperfusion is
one mechanism of ischemic fiber degeneration, causing a
breakdown of the blood-nerve barrier, endoneurial
edema and lipid peroxidation [38]. S. leriifolia extracts
prevented lipid peroxidation and showed antioxidant
activity in this study. These effects and other activities such
as anti-inflammatory effect [13,14] may preserve viability
of nerve conductivity.
Present study showed that S. lerrifolia extracts suppressed
the increase of MDA levels in the rat skeletal muscle and
therefore inhibited lipid peroxidation following
ischemia-reperfusion injury. The inhibition of lipid per-
oxidation and anti-ischemic effects are probably related to
the antioxidant properties and free radical scavengering of
the S. leriifolia extracts.
A number of study have shown that the other species of
Salvia  genus, especially S. miltiorrihiza, possess antioxi-
dant activities [7,39], vasodilatory effects [40], the inhibi-
tion of nitric oxide production [41], glutamate release
[42] and elevation of ATP levels (and probably adenos-
ine) in brain [43].
Several studies have demonstrate that adenosine and its
analogues possess antihypoxic, anti-ischemic [44-46] and
neuromodulatory properties [47] and prevent lipid perox-
idation following ischemia-reperfusion episodes [48]. It
may be possible that adenosine had a role in the anti-
ischemic effects of the extracts. However, this hypothesis
needs to be more investigated.
Conclusion
The results of this study showed the aqueous and the eth-
anolic extracts of S. leriifolia radix had protective effects
against muscle ischemic injury and significantly decreased
the lipid peroxide level in rat muscle following peripheral
ischemia- reperfusion damages. The present study showed
S. leriifolia extracts have protective effect on ischemia
reperfusion injury-induced oxidative stress in rats muscle
that at least partly due to antioxidant properties of S. leri-
ifolia extract.
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